Question
Explain the de novo synthesis pathway of purine ribonuleotides.
Answer :
Word Count : 438
De novo synthesis of purine ribonucleotides is the metabolic pathway by which cells synthesize purine nucleotides from simple, low-molecular-weight precursors rather than recycling preformed purine bases. This pathway is essential in tissues with high rates of cell division and nucleic acid synthesis, such as bone marrow and intestinal epithelium. The process occurs mainly in the cytosol and results in the formation of inosine monophosphate (IMP), which serves as the common precursor for adenine and guanine nucleotides. The purine ring is assembled stepwise on a ribose sugar backbone derived from ribose-5-phosphate, an intermediate of the pentose phosphate pathway. The first committed step is the activation of ribose-5-phosphate by ATP to _____ ____ ______ ____ _____.
__________ _______ _______ ________ _____ _______ __________ ___.
__________ ______ ____ ________ _________ _____ _________ __________ ________ _________ _____.
___ _________ ___ _____ ___ _________ _________ __________ _______ ________ ________.
________ _____ ___ _________ _______ ______ ____ ____.
____ ______ _______ _______ _____ ________ ________ _______ _______ __________ ____.
_____ ___ _________ ______ ____ _________ _________ _______ _________ __________ __________.
____ ___ ________ _____ _________ __________ ______.
_______ _______ ________ ________ ____.
___ __________ ____ ________ _________.
____ ______ ______ ______ ___ ________ ____ _______ _________ _________ _______ ___.
______ __________ _________ _________ __________ ___ _________ ________ ___.
_________ _______ _____ ___ ____ ______ _____ __________ ____ ______.
______ _____ ____ __________ ______ ________ ______ ________.
___ _____ _______ _____ ____ ___ _______ ____ _____ _________ __________.
________ ___ _________ ________ ___.
______ ________ ____ __________ ___ _______ ___ _________ ______ ________ _________ __________.
_______ _____ __________ ______ _________ _______ _____ ______ ___ _____ ________.
___ _____ ___ ______ ________.
_____ ___ _______ _______ __________.
______ _________ _______ _____ __________ ________ ___ ____.
______ _____ ___ _____ ____ _________ _______ _________ __________ ______ ____.
_____ ___ __________ _________ ______ __________ ______ _______ __________ ________ ____.
_____ ______ _______ ______ ___ ___ ________ ____ ______ ____ _______.
_____ ________ _______ _________ _______.
_______ ____ __________ __________ ______ ________.
__________ _________ _________ ________ ____ _______ ___ ___.
__________ ___ ___ ________ ______ _______.
_______ _______ _________ __________ _____.
______ __________ __________ ________ ________ _________ _______ _________.
__________ ______ ____ _______ ___ _______ ______ _________.
_________ ___ ________ _______ __________ _______ _____ _______ _________ ____ ________.
___ _______ _____ ___ ________ ______ __________ ________ _________.
______ ________ ______ _______ ________ _______.
______ _______ ___ ______ __________ __________ ___.
____ _____ ________ _____ _________.
____ __________ ___ ___ ____ ________ ____ _____ _________ _____ _______.
_____ ______ _______ ____ ____ __________.
____ ________ _____ ________ _____ _____.
_____ _________ ____ ______ ___.
__________ __________ __________ _______ __________ _______.
Get Full Answer on WhatsApp
De novo synthesis of purine ribonucleotides is the metabolic pathway by which cells synthesize purine nucleotides from simple, low-molecular-weight precursors rather than recycling preformed purine bases. This pathway is essential in tissues with high rates of cell division and nucleic acid synthesis, such as bone marrow and intestinal epithelium. The process occurs mainly in the cytosol and results in the formation of inosine monophosphate (IMP), which serves as the common precursor for adenine and guanine nucleotides. The purine ring is assembled stepwise on a ribose sugar backbone derived from ribose-5-phosphate, an intermediate of the pentose phosphate pathway. The first committed step is the activation of ribose-5-phosphate by ATP to _____ ____ ______ ____ _____.
__________ _______ _______ ________ _____ _______ __________ ___.
__________ ______ ____ ________ _________ _____ _________ __________ ________ _________ _____.
___ _________ ___ _____ ___ _________ _________ __________ _______ ________ ________.
________ _____ ___ _________ _______ ______ ____ ____.
____ ______ _______ _______ _____ ________ ________ _______ _______ __________ ____.
_____ ___ _________ ______ ____ _________ _________ _______ _________ __________ __________.
____ ___ ________ _____ _________ __________ ______.
_______ _______ ________ ________ ____.
___ __________ ____ ________ _________.
____ ______ ______ ______ ___ ________ ____ _______ _________ _________ _______ ___.
______ __________ _________ _________ __________ ___ _________ ________ ___.
_________ _______ _____ ___ ____ ______ _____ __________ ____ ______.
______ _____ ____ __________ ______ ________ ______ ________.
___ _____ _______ _____ ____ ___ _______ ____ _____ _________ __________.
________ ___ _________ ________ ___.
______ ________ ____ __________ ___ _______ ___ _________ ______ ________ _________ __________.
_______ _____ __________ ______ _________ _______ _____ ______ ___ _____ ________.
___ _____ ___ ______ ________.
_____ ___ _______ _______ __________.
______ _________ _______ _____ __________ ________ ___ ____.
______ _____ ___ _____ ____ _________ _______ _________ __________ ______ ____.
_____ ___ __________ _________ ______ __________ ______ _______ __________ ________ ____.
_____ ______ _______ ______ ___ ___ ________ ____ ______ ____ _______.
_____ ________ _______ _________ _______.
_______ ____ __________ __________ ______ ________.
__________ _________ _________ ________ ____ _______ ___ ___.
__________ ___ ___ ________ ______ _______.
_______ _______ _________ __________ _____.
______ __________ __________ ________ ________ _________ _______ _________.
__________ ______ ____ _______ ___ _______ ______ _________.
_________ ___ ________ _______ __________ _______ _____ _______ _________ ____ ________.
___ _______ _____ ___ ________ ______ __________ ________ _________.
______ ________ ______ _______ ________ _______.
______ _______ ___ ______ __________ __________ ___.
____ _____ ________ _____ _________.
____ __________ ___ ___ ____ ________ ____ _____ _________ _____ _______.
_____ ______ _______ ____ ____ __________.
____ ________ _____ ________ _____ _____.
_____ _________ ____ ______ ___.
__________ __________ __________ _______ __________ _______.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★